HT
VIR icon

HAP Trading’s Vir Biotechnology VIR Stock Holding History

HAP Trading’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,300
Closed -$5K – 1705
2022
Q4 		$5K Buy
22,300
+100
+0.5% +$2.45K ﹤0.01% 1253
2022
Q3 		$9K Buy
22,200
+6,900
+45% +$175K ﹤0.01% 1358
2022
Q2 		$20K Buy
15,300
+2,600
+20% +$60.7K ﹤0.01% 1330
2022
Q1 		$15K Buy
12,700
+1,100
+9% +$32.6K ﹤0.01% 1672
2021
Q4 		$50K Buy
+11,600
New +$454K ﹤0.01% 1482
2021
Q1 		– Sell
-10,900
Closed -$8K – 2503
2020
Q4 		$8K Buy
+10,900
New +$354K ﹤0.01% 1964

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return